RS
EXAS

Ricky Sandler’s Exact Sciences EXAS Stock Holding History

Ricky Sandler’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,469,746
Closed -$97.3M – 65
2022
Q2 		$97.3M Buy
2,469,746
+222,278
+10% +$11.9M 1.93% 22
2022
Q1 		$157M Sell
2,247,468
-557
-0% -$40.7K 1.78% 9
2021
Q4 		$175M Buy
2,248,025
+833,812
+59% +$73.6M 1.66% 12
2021
Q3 		$135M Buy
1,414,213
+317,900
+29% +$33.6M 1.82% 26
2021
Q2 		$136M Buy
1,096,313
+346,225
+46% +$41.3M 1.68% 27
2021
Q1 		$98.8M Sell
750,088
-191,770
-20% -$26.3M 1.22% 39
2020
Q4 		$125M Sell
941,858
-394,897
-30% -$47.8M 1.17% 34
2020
Q3 		$136M Buy
1,336,755
+196,045
+17% +$16.9M 1.34% 19
2020
Q2 		$99.2M Buy
1,140,710
+802,114
+237% +$64.1M 0.98% 34
2020
Q1 		$19.6M Buy
+338,596
New +$27.5M 0.21% 92

Other funds holding EXAS

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Ricky Sandler's EXAS Position: Q3 2022 in Review

Ricky Sandler sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 2,469,746 shares — an estimated $97.3M sold.

Ricky Sandler first reported a position in EXAS in Q1 2020 and held it in 10 quarters. The position peaked at $175M in Q4 2021. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

  • Ricky Sandler reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
  • Ricky Sandler sold 2,469,746 Exact Sciences shares in Q3 2022, an estimated $97.3M.
  • Ricky Sandler first reported a position in Exact Sciences in Q1 2020 and held it in 10 quarters.
  • Ricky Sandler's Exact Sciences position peaked at $175M in Q4 2021.
  • 480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on Eminence Capital's 13F filing for Q3 2022, filed 14 Nov 2022.